Viewing Study NCT06601127


Ignite Creation Date: 2025-12-25 @ 5:07 AM
Ignite Modification Date: 2026-02-20 @ 1:29 PM
Study NCT ID: NCT06601127
Status: RECRUITING
Last Update Posted: 2025-03-07
First Post: 2024-09-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Tiprogrel in the Treatment of High-risk Patients with Acute Ischemic Cerebrovascular Events (THRIVE).
Sponsor: Tianjin Institute of Pharmaceutical Research Co., Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module